Cargando…

Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry

Detalles Bibliográficos
Autores principales: Call, Jerry W., Wang, Yu, Montoya, Denisse, Scherzer, Norman J., Heinrich, Michael C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503372/
https://www.ncbi.nlm.nih.gov/pubmed/31080577
http://dx.doi.org/10.1186/s13569-019-0117-2
_version_ 1783416396988809216
author Call, Jerry W.
Wang, Yu
Montoya, Denisse
Scherzer, Norman J.
Heinrich, Michael C.
author_facet Call, Jerry W.
Wang, Yu
Montoya, Denisse
Scherzer, Norman J.
Heinrich, Michael C.
author_sort Call, Jerry W.
collection PubMed
description
format Online
Article
Text
id pubmed-6503372
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65033722019-05-10 Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry Call, Jerry W. Wang, Yu Montoya, Denisse Scherzer, Norman J. Heinrich, Michael C. Clin Sarcoma Res Correction BioMed Central 2019-05-07 /pmc/articles/PMC6503372/ /pubmed/31080577 http://dx.doi.org/10.1186/s13569-019-0117-2 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correction
Call, Jerry W.
Wang, Yu
Montoya, Denisse
Scherzer, Norman J.
Heinrich, Michael C.
Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry
title Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry
title_full Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry
title_fullStr Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry
title_full_unstemmed Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry
title_short Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry
title_sort correction to: survival in advanced gist has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from life raft group registry
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503372/
https://www.ncbi.nlm.nih.gov/pubmed/31080577
http://dx.doi.org/10.1186/s13569-019-0117-2
work_keys_str_mv AT calljerryw correctiontosurvivalinadvancedgisthasimprovedovertimeandcorrelateswithincreasedaccesstopostimatinibtyrosinekinaseinhibitorsresultsfromliferaftgroupregistry
AT wangyu correctiontosurvivalinadvancedgisthasimprovedovertimeandcorrelateswithincreasedaccesstopostimatinibtyrosinekinaseinhibitorsresultsfromliferaftgroupregistry
AT montoyadenisse correctiontosurvivalinadvancedgisthasimprovedovertimeandcorrelateswithincreasedaccesstopostimatinibtyrosinekinaseinhibitorsresultsfromliferaftgroupregistry
AT scherzernormanj correctiontosurvivalinadvancedgisthasimprovedovertimeandcorrelateswithincreasedaccesstopostimatinibtyrosinekinaseinhibitorsresultsfromliferaftgroupregistry
AT heinrichmichaelc correctiontosurvivalinadvancedgisthasimprovedovertimeandcorrelateswithincreasedaccesstopostimatinibtyrosinekinaseinhibitorsresultsfromliferaftgroupregistry